NCT05610540 is a clinical trial of TECNIS Synergy IOL in IOL, sponsored by Bucci Laser Vision Institute.

Who is sponsoring NCT05610540?

NCT05610540 is sponsored by Bucci Laser Vision Institute.

What drugs are being tested in NCT05610540?

Interventions in NCT05610540: TECNIS Synergy IOL, AcrySof PanOptix Trifocal IOL.

What condition does NCT05610540 study?

NCT05610540 studies IOL, Cataract, Patient Satisfaction.

Is NCT05610540 still recruiting?

NCT05610540 is currently completed. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05610540

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Preference and Visual Quality With Contralateral Synergy Versus Panoptix

Completed Last updated 27 July 2023

What this trial tests

trial testing TECNIS Synergy IOL in IOL in 20 participants. Completed in 31 May 2023.

Timeline

12 April 2022

Primary endpoint
21 February 2023

31 May 2023

Quick facts

Lead sponsor	Bucci Laser Vision Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	12 April 2022
Primary completion	21 February 2023
Estimated completion	31 May 2023
Sites	1 location across United States

Drugs / interventions tested

TECNIS Synergy IOL
AcrySof PanOptix Trifocal IOL

Conditions studied

IOL — all drugs for IOL →
Cataract — all drugs for Cataract →
Patient Satisfaction — all drugs for Patient Satisfaction →

Sponsor

Bucci Laser Vision Institute

Who can join

40 and older, any sex, with IOL or Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare the visual quality and patient preference of the Synergy IOL versus the PanOptix IOL when one of each lens is placed in the same patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Bucci Laser Vision Institute trials

Trials by the same sponsor.

NCT06016231 — Clinical Outcomes of Patients with a Light Adjustable Lens (LAL) in At Least One Eye · completed
NCT04120987 — Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra · Phase 4 · withdrawn
NCT04134507 — Patient Satisfaction in Post-LASIK Patients With Presbyopia-Correcting IOLs vs. Post-Lasik Patients With Monofocal IOLs · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05610540 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bucci Laser Vision Institute
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05610540.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing